Glenmark Pharmaceuticals reports 2-fold jump in Q1 consolidated net profit

17 Aug 2020 Evaluate

Glenmark Pharmaceuticals has reported results for the first quarter ended June 30, 2020.

The company has reported a 2-fold jump net profit from continuing operations at Rs 462.48 crore for the quarter under review as compared to Rs 227.84 crore for the same quarter in the previous year. Total income of the company increased by 15.98% at Rs 1,817.77 crore for Q1FY21 as compared Rs 1,567.33 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 2-fold jump in its net profit from continuing operations at Rs 254.04 crore for the quarter under review as compared to Rs 109.28 crore for the same quarter in the previous year. Total income of the company increased by 3.39% at Rs 2,403.30 crore for Q1FY21 as compared Rs 2,324.55 crore for the corresponding quarter previous year.

Glenmark Pharma Share Price

1964.65 11.75 (0.60%)
11-Dec-2025 12:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1799.25
Dr. Reddys Lab 1271.25
Cipla 1507.40
Zydus Lifesciences 924.35
Lupin 2079.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×